TRDA
Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)
TRDA fundamentals
Entrada Therapeutics (TRDA) released its earnings on Aug 6, 2025: revenue was 1.95M (YoY -97.94%), missed estimates; EPS was -1.04 (YoY -167.10%), missed estimates.
Revenue / YoY
1.95M
-97.94%
EPS / YoY
-1.04
-167.10%
Report date
Aug 6, 2025
EPS
Actual | -9.78 | -0.89 | -0.69 | -0.74 | -0.8 | -0.79 | -0.21 | -0.78 | 1.02 | -0.29 | 0.68 | 1.55 | -0.35 | 0.03 | -0.42 | -1.04 |
Forecast | -0.87 | -1.285 | -0.655 | -0.725 | -0.76 | -0.8273 | -0.6512 | -0.6898 | -0.735 | -0.1684 | -0.594 | 0.3614 | -0.728 | -0.6698 | -0.7886 | -0.8472 |
Surprise | -1024.14% | +30.74% | -5.34% | -2.07% | -5.26% | +4.51% | +67.75% | -13.08% | +238.78% | -72.21% | +214.48% | +328.89% | +51.92% | +104.48% | +46.74% | -22.76% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 25.26M | 18.17M | 43.73M | 41.85M | 59.12M | 94.69M | 19.57M | 37.40M | 20.56M | 1.95M |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 7.00M | 9.78M | 9.60M | 23.69M | 14.98M | 51.86M | 12.32M | 13.12M | 10.17M | 9.65M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +260.86% | +85.86% | +355.69% | +76.66% | +294.75% | +82.60% | +58.83% | +185.04% | +102.12% | -79.80% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for Entrada Therapeutics year over year?What were the key takeaways from Entrada Therapeutics's earnings call?What were the key takeaways from Entrada Therapeutics’s earnings call?What is the market's earnings forecast for Entrada Therapeutics next quarter?What guidance did Entrada Therapeutics's management provide for the next earnings period?What factors drove the changes in Entrada Therapeutics's revenue and profit?What is Entrada Therapeutics's latest dividend and current dividend yield?Did Entrada Therapeutics beat or miss consensus estimates last quarter?
